NASDAQ:RVPH
Reviva Pharmaceuticals Holdings, Inc.
- Stock
Last Close
1.71
17/05 20:00
Market Cap
108.04M
Beta: 0.10
Volume Today
301.67K
Avg: 140.38K
PE Ratio
−2.39
PFCF: −4.77
Feb '20 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
asset turnover | |||||
cash per share | 23.55 - | 2.86 87.85% | 2.01 29.85% | 0.95 52.72% | |
company equity multiplier | -0.00 - | 1.18 309,072.87% | 1.09 7.18% | 1.54 40.35% | |
days of inventory outstanding | |||||
days of payables outstanding | 507.68 - | ||||
days of sales outstanding | |||||
dividend yield | |||||
ebit per revenue | |||||
ebt per ebit | 2.24 - | 1.55 30.79% | 0.84 45.75% | 1.00 18.71% | |
effective tax rate | -0.00 - | -0.00 77.63% | -0.00 233.36% | -0.00 21.18% | |
enterprise value multiple | -87.82 - | -7.73 91.20% | -1.29 83.28% | -2.67 106.76% | |
fixed asset turnover | |||||
free cash flow per share | -0.08 - | -1.22 1,443.43% | -0.72 40.73% | -0.97 34.69% | |
gross profit margin | |||||
interest coverage | -0.80 - | -1.68 108.68% | -4.19K 249,729.02% | -132.97 96.82% | |
inventory turnover | |||||
long term debt to capitalization | |||||
net income per ebt | 1.00 - | 1.00 0.07% | 1.00 0.05% | 1.00 0.01% | |
net profit margin | |||||
operating cash flow per share | -0.08 - | -1.22 1,443.43% | -0.72 40.73% | -0.97 34.69% | |
operating profit margin | |||||
payables turnover | 0.72 - | ||||
pretax profit margin | |||||
price fair value | -4.30 - | 3.60 183.85% | 1.49 58.63% | 6.73 351.95% | |
receivables turnover | |||||
return on assets | -325.70 - | -0.43 99.87% | -0.27 37.15% | -1.29 373.97% | |
return on capital employed | 0.06 - | -0.33 692.29% | -0.35 6.11% | -1.89 442.56% | |
return on equity | 0.12 - | -0.51 509.60% | -0.30 41.66% | -1.98 565.22% | |
total debt to capitalization | -1.24 - |
All numbers in USD (except ratios and percentages)